These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Sarris J; LaPorte E; Schweitzer I Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). Anke J; Ramzan I J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747 [TBL] [Abstract][Full Text] [Related]
5. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850 [TBL] [Abstract][Full Text] [Related]
6. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum. Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of kava in the treatment of anxiety disorders. Singh YN; Singh NN CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029 [TBL] [Abstract][Full Text] [Related]
13. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. Thomsen M; Schmidt M J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846 [TBL] [Abstract][Full Text] [Related]
15. [Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety]. Schmidt M; Nahrstedt A; Lüpke NP Wien Med Wochenschr; 2002; 152(15-16):382-8. PubMed ID: 12244883 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Malsch U; Kieser M Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083 [TBL] [Abstract][Full Text] [Related]
17. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Weiss J; Sauer A; Frank A; Unger M Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732 [TBL] [Abstract][Full Text] [Related]
18. Kava treatment in patients with anxiety. Geier FP; Konstantinowicz T Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364 [TBL] [Abstract][Full Text] [Related]
19. Herb-drug interactions: interactions between kava and prescription medications. Bressler R Geriatrics; 2005 Sep; 60(9):24-5. PubMed ID: 16153141 [TBL] [Abstract][Full Text] [Related]
20. Safety of kava for patients with mild anxiety disorders. Saeed SA; Bloch RM; Antonacci DJ Am Fam Physician; 2008 Aug; 78(4):433-4. PubMed ID: 18756649 [No Abstract] [Full Text] [Related] [Next] [New Search]